Skip to main content

Advertisement

Log in

Phyllodes Tumors of the Breast—Experience in a Tertiary Care Center

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Phyllodes tumors (PTs) are rare neoplasms of the breast that are a challenge in clinical practice. Though mostly benign, they are notorious for local recurrence, requiring adjuvant treatments. This study was planned to report the clinicopathological features and outcomes of patients with PT treated at our center. Details of all patients who underwent surgery for PT in the last 6 years (December 2017–December 2023) were obtained from our prospectively maintained database. The demographic, clinical, radiological, pathological, and follow-up details were recorded and analyzed. Statistical analyses were carried out with Jamovi version 2.3.18. Out of 61 suspected PTs by triple assessment, 9 were excluded due to a non-phyllodes diagnosis on histopathology. We included 52 women with a mean age of 38.2 ± 11.0 years, most of whom were premenopausal (57.7%). BI-RADS 4 was the most common finding on radiological assessment (65.4%). Core needle biopsy (CNB) was the most frequently employed modality for histological diagnosis preoperatively (65.4% of cases). Wide local excisions (WLE) and mastectomies were done in 63.5% and 36.5% of patients, respectively. Benign, borderline, and malignant phyllodes constituted 67.3%, 15.4%, and 17.3% of tumors, respectively. Patients undergoing breast conservation surgery (BCS) had a significantly smaller mean tumor diameter than those who underwent a mastectomy (p < 0.001). Overall, the margin positivity rate was 34.6%. Patients undergoing mastectomy developed more local recurrence compared to WLE, although the difference was not significant (p = 0.400). The outcome following surgical excisions of large PTs in terms of margin positivity and local recurrence is the same, irrespective of whether BCS or mastectomy is done. A negative pathological margin width of > 1 mm appears acceptable. Malignant phyllodes with positive margins are associated with a higher rate of recurrence but positive margins in patients with other subtypes may not translate into recurrence, at least in the short term.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Lissidini G, Mulè A, Santoro A et al (2022) Malignant phyllodes tumor of the breast: a systematic review. Pathologica 114(2):111–120. https://doi.org/10.32074/1591-951X-754

    Article  PubMed  PubMed Central  Google Scholar 

  2. Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK (2006) Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 107(9):2127–2133. https://doi.org/10.1002/cncr.22228

    Article  PubMed  Google Scholar 

  3. Zhang Y, Kleer CG (2016) Phyllodes tumor of the breast: histopathologic features, differential diagnosis, and molecular/genetic updates. Arch Pathol Lab Med 140(7):665–671. https://doi.org/10.5858/arpa.2016-0042-RA

    Article  PubMed  Google Scholar 

  4. Fiks A (1981) Cystosarcoma phyllodes of the mammary gland—Müller’s tumor. For the 180th birthday of Johannes Müller. Virchows Arch A Pathol Anat Histol 392(1):1–6. https://doi.org/10.1007/BF00430543

    Article  CAS  PubMed  Google Scholar 

  5. Belkacémi Y, Bousquet G, Marsiglia H et al (2008) Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 70(2):492–500. https://doi.org/10.1016/j.ijrobp.2007.06.059

    Article  PubMed  Google Scholar 

  6. Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP (2001) Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 27(8):723–730. https://doi.org/10.1053/ejso.2001.1207

    Article  CAS  PubMed  Google Scholar 

  7. Jang JH, Choi MY, Lee SK et al (2012) Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol 19(8):2612–2617. https://doi.org/10.1245/s10434-012-2307-5

    Article  PubMed  Google Scholar 

  8. Rosenberger LH, Thomas SM, Nimbkar SN et al (2021) Contemporary multi-institutional cohort of 550 cases of phyllodes tumors (2007–2017) demonstrates a need for more individualized margin guidelines. J Clin Oncol 39(3):178–189. https://doi.org/10.1200/JCO.20.02647

    Article  CAS  PubMed  Google Scholar 

  9. Akrami M, Tahmasebi S, Talei A, Abdollahi A, Hosseini S, Namazi M (2015) Clinical outcome of patients with breast phyllodes tumors: a retrospective analysis of 129 cases in Shiraz, Southern Iran. Middle East Journal of Cancer 6(4):267–273

    Google Scholar 

  10. Shankar M, Khambra P (2020) Phyllodes tumors of the breast treated in a tertiary health care center:case series. Int J Sci Res 9(3):41–41. https://doi.org/10.36106/ijsr

  11. Sain B, Gupta A, Ghose A et al (2023) Clinico-pathological factors determining recurrence of phyllodes tumors of the breast: the 25-year experience at a tertiary cancer centre. J Pers Med 13(5):866. https://doi.org/10.3390/jpm13050866

    Article  PubMed  PubMed Central  Google Scholar 

  12. Karim RZ, Gerega SK, Yang YH et al (2009) Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast 18(3):165–170. https://doi.org/10.1016/j.breast.2009.03.001

    Article  CAS  PubMed  Google Scholar 

  13. Barrio AV, Clark BD, Goldberg JI et al (2007) Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 14(10):2961–2970. https://doi.org/10.1245/s10434-007-9439-z

    Article  PubMed  Google Scholar 

  14. Ramakant P, Chakravarthy S, Cherian JA, Abraham DT, Paul MJ (2013) Challenges in management of phyllodes tumors of the breast: a retrospective analysis of 150 patients. Indian J Cancer 50(4):345–348. https://doi.org/10.4103/0019-509X.123625

    Article  CAS  PubMed  Google Scholar 

  15. Sanjay S, Ketul P, Mohit S et al (2021) Study of clinicopathological factors and their impact on survival in phyllodes tumour of breast at tertiary care cancer centre in India. Cancer Treat Res Commun 29:100482. https://doi.org/10.1016/j.ctarc.2021.100482

    Article  PubMed  Google Scholar 

  16. Karim MO, Khan KA, Khan AJ, Javed A, Fazid S, Aslam MI (2020) Triple assessment of breast lump: should we perform core biopsy for every patient? Cureus 12(3):e7479. https://doi.org/10.7759/cureus.7479

    Article  PubMed  PubMed Central  Google Scholar 

  17. Tan BY, Acs G, Apple SK et al (2016) Phyllodes tumours of the breast: a consensus review. Histopathology 68(1):5–21. https://doi.org/10.1111/his.12876

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lawton TJ, Acs G, Argani P et al (2014) Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors. Int J Surg Pathol 22:695–698. https://doi.org/10.1177/1066896914548763

    Article  PubMed  PubMed Central  Google Scholar 

  19. Leibl S, Gogg-Kammerer M, Sommersacher A, Denk H, Moinfar F (2005) Metaplastic breast carcinomas: are they of myoepithelial differentiation? immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol 29(3):347–353. https://doi.org/10.1097/01.pas.0000152133.60278.d2

    Article  PubMed  Google Scholar 

  20. Moutte A, Chopin N, Faure C et al (2016) Surgical management of benign and borderline phyllodes tumors of the breast. Breast J 22(5):547–552. https://doi.org/10.1111/tbj.12623

    Article  PubMed  Google Scholar 

  21. Lu Y, Chen Y, Zhu L et al (2019) Local recurrence of benign, borderline, and malignant phyllodes tumors of the breast: a systematic review and meta-analysis. Ann Surg Oncol 26(5):1263–1275. https://doi.org/10.1245/s10434-018-07134-5

    Article  PubMed  Google Scholar 

  22. Ravindhran B, Rajan S (2020) Predictive factors of early recurrence in patients with phyllodes tumor of the breast. Eur J Breast Health 17(1):10–14. https://doi.org/10.5152/ejbh.2020.5712

    Article  PubMed  PubMed Central  Google Scholar 

  23. de Roos WK, Kaye P, Dent DM (1999) Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. Br J Surg 86(3):396–399. https://doi.org/10.1046/j.1365-2168.1999.01035.x

    Article  PubMed  Google Scholar 

  24. Chen WH, Cheng SP, Tzen CY et al (2005) Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 91(3):185–194. https://doi.org/10.1002/jso.20334

    Article  PubMed  Google Scholar 

  25. Barth RJ Jr, Wells WA, Mitchell SE, Cole BF (2009) A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol 16(8):2288–2294. https://doi.org/10.1245/s10434-009-0489-2

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tan EY, Tan PH, Yong WS, et al (2006) Recurrent phyllodes tumours of the breast: pathological features and clinical implications [published correction appears in ANZ J Surg. 2006 Oct;76(10):956. Hoon, Tan Puay [corrected to Tan, Puay Hoon]; Hui, Ho G [corrected to Ho, Gay Hui]]. ANZ J Surg 76(6):476–480. https://doi.org/10.1111/j.1445-2197.2006.03754.x

Download references

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chandan Kumar Jha.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anand, A., Jha, C.K., Sinha, U. et al. Phyllodes Tumors of the Breast—Experience in a Tertiary Care Center. Indian J Surg Oncol (2024). https://doi.org/10.1007/s13193-024-01926-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13193-024-01926-w

Keywords

Navigation